Amino acid biology is fundamental to life, regulating biological pathways critical to health. Diseases develop when these pathways become dysregulated. Pronutria Biosciences is a clinical stage company providing first-in-class precision therapeutic solutions to these diseases with a focus on restoring amino acid biology. Using insights from a clinically validated body of evidence, we are pioneering a new therapeutic modality: amino acid mediated therapeutics. Our novel treatment class allows us to precisely target biologies that were previously inaccessible, providing a unique treatment opportunity in a variety of serious diseases. 
We are innovating at the frontier of amino acid biology. We have generated a library of over 1 billion protein sequences and have developed the proprietary tools to identify disease specific therapeutic candidates.  We have assembled a world-class team of industry leaders, defined by their commitment to profoundly improve the lives of patients and families. Together, we are singularly focused on developing solutions for patients facing serious metabolic disorders, neurodegenerative diseases and critical care conditions amongst others with little or no standard of care.

"I am excited to lead the group of world-class scientists at Pronutria Biosciences using regenerative therapeutics to improve the lives of patients and their families."
- Peter Mueller, President of R&D, and Chief Scientific Officer